GRAS Notices
-
GRN No. 949
Bacillus coagulans strain DSM 17654 spore preparation
Intended Use: | Intended for use at a maximum level of 2 x 109 colony forming units (CFU)/serving as an ingredient in baked goods and baking mixes; breakfast cereals; beverages and beverage bases; coffee and tea; milk and milk products; dairy product analogs; fruit juices; condiments and relishes; confections and frostings; frozen dairy desserts and mixes; fruit and water ices; jams and jellies; gelatins, puddings and fillings; grain products and pastas; hard and soft candy; chewing gum; extracts, flavorings, herbs, seeds, spices, seasonings and blends; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soups and soup mixes; sugar; and sweet sauces, toppings and syrups (excluding infant formula, foods formulated for infants, or any products under the jurisdiction of the United States Department of Agriculture). |
---|---|
Basis: | Scientific procedures |
Notifier: | Advanced Enzymes Technologies Ltd. |
Notifier Address: |
5th Floor, A wing, Sun Magnetica L.I.C. Service Road, Louiswadi Thane (W) 400 064 India |
GRAS Notice (releasable information): | GRN 949 with amendments (in PDF) (21.4 MB) |
Date of closure: | Jan 7, 2021 |
FDA's Letter: | FDA has no questions (in PDF) |
-